z-logo
open-access-imgOpen Access
Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer
Author(s) -
Bhishamjit S. Chera,
Sunil Kumar,
Colette J. Shen,
Robert J. Amdur,
Roi Dagan,
Rebecca Green,
Emily C. Goldman,
Jared Weiss,
Juneko E. GrilleyOlson,
Shetal Patel,
Adam M. Zanation,
Trevor Hackman,
Jeff Blumberg,
Samip Patel,
Brian D. Thorp,
Mark C. Weissler,
Wendell G. Yarbrough,
Nathan Sheets,
William M. Mendenhall,
Xianming Tan,
Gaorav P. Gupta
Publication year - 2020
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.19.02444
Subject(s) - medicine , biomarker , chemoradiotherapy , cancer , biopsy , clinical endpoint , surrogate endpoint , prospective cohort study , circulating tumor cell , oncology , gastroenterology , clinical trial , metastasis , biochemistry , chemistry
Plasma circulating tumor human papillomavirus DNA (ctHPVDNA) is a sensitive and specific biomarker of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC). We investigated whether longitudinal monitoring of ctHPVDNA during post-treatment surveillance could accurately detect clinical disease recurrence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom